How do we adapt hospital care in patients with hyperglycemia and COVID-19?
DOI:
https://doi.org/10.47196/diab.v55i2.477Keywords:
hyperglycemia, covid-19Abstract
The COVID-19 pandemic that is going through the entire world caused a situation of global crisis in all health systems. This crisis forced us to make emergent changes to achieve adequate inpatient care in critical and non-critical areas. Therefore, the health personnel (HCP) faced new challenges, and resorted to tools for outpatient use (such as continuous glucose monitoring and telemedicine, which facilitated communication spaces between the HCP with the hospitalized patient), and also used the technology for the transmission of diagnoses and treatments for patients at a distance.
References
I. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-1062.
II. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, diabetes mellitus. NHI, Bethesda, Maryland. Am J Physiol Endocrinol Metab 2020; 318(5):E736-E741.
III. Ushigome E, Yamazaki M, Hamaguchi M, et al. Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes. Diabetes Technol Ther 2020; 22:1-3.
IV. Agarwal S, Mathew J, Davis G, Umpierrez G, et al. Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care 2021 Mar; 44(3):847-849.
V. Garelli F, Sánchez-Peña R, Krochik G, Grosembacher L, et al. Remote glucose monitoring platform for multiple simultaneous patients at coronavirus disease 2019 intensive care units: case report including adults and children. Diabetes Technology & Therapeutics 2021; Vol 23, Num 5. DOI:10.1089/dia.2020.0556
VI. Krochik G, Prieto M, Martínez C, et al. Reporte de altos requerimientos de insulina en pacientes críticos pediátricos con COVID-19. Experiencia con monitoreo remoto continuo de glucosa. Revista de la Sociedad Argentina de Diabetes 2021; Vol. 55 Nº 2: 70-74.
VII. Reutrakul S, Genco M, Salinas H, et al. Feasibility of inpatient continuous glucose monitoring during the COVID-19 pandemic: early experience. Diabetes Care 2020; 43: e137-e138.
VIII. Shehav-Zaltzman G, Segal G, Konvalina N, Tirosh A. Remote glucose monitoring of hospitalized, quarantined patients with diabetes and COVID-19. Diabetes Care 2020; 43:e75-e76 4.
IX. Galindo R, Aleppo A, Klonoff D, et al. Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. Journal of Diabetes Science and Technology 2020; 14(4):822-832.
X. Galindo R, Umpierrez G, Rushakoff R, et al. Continuous glucose monitors and automated insulin dosing systems in the Hospital Consensus Guideline. Journal of Diabetes Science and Technology 2020; 14(6):1035-1064.
XI. Pérez-Guzmán M, Trisha-Shang T, Zhang J, et al. Continuous glucose monitoring in the hospital. Endocrinol Metab 2021; 36:240-255.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 on behalf of the authors. Reproduction rights: Argentine Diabetes Society.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
